Detail akcie BioNxs Gene Lab Rg online

Business Summary: BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, BioNexus Gene Lab Corp revenues decreased 1% to $6.9M. Net loss increased 56% to $1.9M. Revenues reflect Chemrex segment decrease of 31% to $4.8M, BioNexus Malaysisa segment decrease of 27% to $8K. Higher net loss reflects Chemrex segment loss totaling $655K vs. income of $125K. Basic Earnings per Share excluding Extraordinary Items decreased from -$0.69 to -$1.08.